Extreme heat: why take care of your biological clock?
According to Public Health France, with four heatwave episodes affecting 80% of the French population, the summer of 2025 was the third hottest summer in France since 1900. In light of the climate changes observed in recent years, it is important to recognize that these episodes of extreme heat will no longer be commonplace.
Published 10 / 07 / 2026Alzheimer's disease: a BIN1 isoform toxic to neurons
For many years, Dr. Jean Charles Lambert's laboratory has been a world leader in Alzheimer's disease research, particularly in the study of its genetic component. His work has significantly contributed to the identification of most of the genetic factors involved in the development of this disease. Among them, the gene […]
Published 07 / 07 / 2026Mortality in France: what the figures reveal
Three studies by the Directorate for Research, Studies, Evaluation and Statistics (DREES), the National Institute of Health and Medical Research (INSERM), and Public Health France, published on June 23, 2026, provide a better understanding of the main causes of death in France and their recent evolution. Once adjusted for the effect of population aging, overall mortality continued its decline in 2024 compared to […]
Published 06 / 07 / 2026Ozempic and Wegovy: what you really need to know about GLP-1 analogues
Ozempic, Wegovy, Mounjaro… in just a few months, these brand names have become familiar to the general public. Behind them lies the same therapeutic class: GLP-1 (Glucagon-Like Peptide 1) analogs, also known as GLP-1 receptor agonists. Hailed as the “scientific breakthrough of 2023” by the journal Science, their story is much more complex.
Published 06 / 07 / 2026Diabetes
Inter-organ dialogue for a better understanding of cardiometabolic diseases
Dr. Jean-Sébastien Annicotte, Director of the "Molecular and Cellular Pathophysiology of Cardiometabolic Diseases" team within the INSERM UMR 1167 Rid-Age research unit on the Institut Pasteur campus in Lille, conducts research on cardiometabolic diseases, including diabetes, obesity, and heart failure. He seeks to understand how environmental factors, such as […]
Published 30 / 06 / 2026Aging and diabetes: two distinct epigenetic trajectories in the pancreas
Aging is one of the main risk factors for type 2 diabetes, but the biological mechanisms linking age to the decline in pancreatic function remain poorly understood. In a recent study, Amna Khamis and Philippe Froguel (INSERM U1283, CNRS UMR8199, ULille, Lille University Hospital) performed an integrated analysis of the epigenome, the […]
Published 24 / 06 / 2026A deep-sea peptide opens new avenues against lung infections in cystic fibrosis
Chronic lung infections are a major cause of morbidity in patients with cystic fibrosis. Aurélie Tasiemski from the Lille Center for Infection and Immunity (CNRS UMR9017, INSERM U1019, University of Lille, IPL) is exploring the oceans in search of a miracle cure. Her idea: to search the deep sea for novel molecules potentially capable of eliminating […]
Published 23 / 06 / 2026A new therapeutic target against tuberculosis identified by teams from Lille
Tuberculosis (TB) remains the world's deadliest infectious disease and a major public health challenge, particularly due to the emergence of multidrug-resistant and extensively drug-resistant strains. Among the new therapeutic options, pretomanide recently received marketing authorization and is now used in combination with other drugs.
Published 23 / 06 / 2026
